AI Article Synopsis
- * A case study is presented of a metastatic melanoma patient who had been successfully treated with anti PD-1 therapy and contracted COVID-19, ultimately recovering fully.
- * A review of existing literature indicates limited evidence, but suggests it's possible for cancer patients on immunotherapy to continue their treatment while managing COVID-19.
Article Abstract
The outbreak of COVID-19 pandemia is a major health worldwide concern. Patients with cancer might have a worse outcome, because of the immunosuppression determined by the tumor itself and anti-cancer treatments, including chemotherapy and radiotherapy. The impact and course of viral infection in patients receiving immunotherapy remains unknown. We report the case of a patient with metastatic melanoma, long responder to anti PD-1 blockade who got infected with Sars CoV-2, recovering without sequelae. A critical review of literature was performed. Limited data available in literature support the possibility to continue the immunotherapy in patients with cancer under control.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/07357907.2020.1844893 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!